Clinical Trials · NCT02862782
Combination of Gonadotropin-releasing Hormone Agonist and Human Chorionic Gonadotropin Triggered by Normal Responder in GnRH-antagonist Cycles
- Phase
- Phase 3
- Recruitment status
- Unknown
- Sponsor
- Tel-Aviv Sourasky Medical Center
- Enrollment
- 1,000
- Start date
- Sep 2016
- Locations
- See registry
- Primary endpoint
- Clinical pregnancies rate